Supernus Pharmaceuticals | SUPN - 股票

金融业

USD

USD 1.5B

现金及等价物

USD 184.87M

USD 49.04M

USD 731.58M

USD 373.93M

USD 40.98M

USD -35.25M

USD 29.23M

674

EPS每股收益

USD 0.6

股本和储备

USD 1.08B

USD 129.36M

债务利息支出

USD 910K

USD 2.02M

USD 400.38M

USD 2.43B

USD -2.29M

USD 1.08B

USD -35.25M

普通股股本

USD 58.04M

44.21

USD -5.95M

USD 207.71M

销售和管理费用

USD 118.23M

USD 110.77M

贸易债权人

USD 10.17M

应收帐款人

USD 182.18M

	股票	更改		日
Abbott	USD 6.99B		501M	2026-03
ANI Pharmaceuticals	USD 143.47M		401K	2026-03
Aurora Cannabis	CAD 230.56M		8.6M	2025-12
Bristol-Myers Squibb	USD 2.76B		66M	2026-03
Canopy Growth	CAD 105.56M		3.18M	2025-12
Cara Therapeutics	USD 900K		0	2025-03
Corcept Therapeutics	USD 12.89M		22K	2026-03
Eisai	JPY 236.46B		9.14B	2025-09
Eli Lilly	USD 14.53B		785M	2026-03
Novo Nordisk	DKK 45.65B		21.26B	2025-06
Pacira	USD 150.37M		2.49M	2026-03
Perrigo	USD 1.12B		27.6M	2026-03
Pfizer	USD 10.67B		13M	2026-03
Supernus Pharmaceuticals	USD 110.77M		1.71M	2026-03
United Therapeutics	USD 178.3M		4.8M	2026-03
Xeris Pharmaceuticals	USD 74.23M		5.56M	2026-03